openPR Logo
Press release

Lysosomal Storage Diseases Market 2023 - Future Plans and Industry Growth with Quantitative And Qualitative Analysis

02-14-2023 04:44 AM CET | Health & Medicine

Press release from: Persistence Market Research

Lysosomal Storage Diseases Market 2023 - Future Plans

The Lysosomal Storage Diseases (LSD) market is a niche segment of the pharmaceutical industry that focuses on developing treatments for rare genetic disorders that affect the lysosomal system. These diseases are caused by mutations in lysosomal enzymes, which leads to the accumulation of toxic substances in cells and can result in a wide range of symptoms, including developmental delays, organ damage, and early death.

Request For Free Sample Report of "Lysosomal Storage Diseases Market"@ https://www.persistencemarketresearch.com/samples/3145

There are over 50 different types of lysosomal storage diseases, each with its own specific set of symptoms and progression. Some of the more common types include Gaucher disease, Niemann-Pick disease, and Pompe disease. Symptoms of lysosomal storage diseases can range from mild to severe and can affect multiple organ systems, including the brain, liver, spleen, and bones.

The market for lysosomal storage diseases is expected to grow significantly in the coming years, driven by factors such as an increasing prevalence of these disorders, the development of new therapies and treatments, and the expanding global market for orphan drugs.

 Companies

Shire PLC
Pfizer, Inc.
Sanofi
BioMarin Pharmaceutical Inc.
Actelion Ltd.
Raptor Pharmaceutical Corp.
Protalix Biotherapeutics Inc.
Amicus Therapeutics, Inc.
Others

Buy Full Report Now @ https://www.persistencemarketresearch.com/checkout/3145

There are several companies that are actively developing therapies for lysosomal storage diseases, including enzyme replacement therapies, gene therapies, and small molecule therapies. Many of these therapies are in late-stage clinical development or have already received regulatory approval and are available on the market.

Overall, the lysosomal storage diseases market is expected to continue to grow in the coming years as more treatments become available and the demand for these therapies increases.

Regional Analysis

The global lysosomal storage diseases therapeutics market is segmented into the five key regions of North America, Latin America, Europe, Asia Pacific (APAC), and Middle East & Africa (MEA). In terms of value, Europe is estimated to be the dominant market in the global lysosomal storage diseases therapeutics market in 2016 and is expected to register a CAGR of 10.2% over the forecast period to reach a market valuation of US$ 5,105.1 Mn by 2026 end. North America is expected to be the second most lucrative market in the global lysosomal storage diseases therapeutics market over the forecast period.

The North America market is estimated to account for 32.2% revenue share of the global lysosomal storage diseases therapeutics market by 2016 end. The Asia Pacific lysosomal storage diseases therapeutics market is anticipated to represent absolute $ opportunity of US$ 59.1 Mn in 2017 over 2016. The lysosmal storage diseases therapeutics market in the MEA region is estimated to increase 2.5X in value over the forecast period.

Request Customization @ https://www.persistencemarketresearch.com/request-customization/3145

Related Market Research Report:

Dental Imaging market - https://www.globenewswire.com/en/news-release/2022/10/17/2535642/0/en/Dental-Imaging-Market-growth-expanding-at-a-CAGR-of-9-4-from-2022-to-2032-Persistence-Market-Research.html

Wearable Injectors market - https://www.globenewswire.com/en/news-release/2022/10/13/2534053/0/en/Wearable-Injectors-Market-sales-are-expected-to-reach-US-17-6-Bn-by-2031-Persistence-Market-Research.html

Botulinum Toxin market - https://www.globenewswire.com/en/news-release/2022/10/13/2534010/0/en/Botulinum-Toxin-Market-is-set-to-expand-at-a-CAGR-of-6-9-by-the-end-of-2031-Persistence-Market-Research.html

Metabolic Testing market - https://www.globenewswire.com/en/news-release/2022/10/12/2533081/0/en/Metabolic-Testing-Market-to-ride-on-enhancement-in-predictive-analytics-reaching-US-1-2-Bn-by-the-year-2032-Persistence-Market-Research.html

Respiratory Care Devices market - https://www.globenewswire.com/en/news-release/2022/09/27/2523525/0/en/Global-Respiratory-Care-Devices-Market-expanding-at-a-high-value-CAGR-of-8-3-by-the-end-of-2032.html

About Us

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lysosomal Storage Diseases Market 2023 - Future Plans and Industry Growth with Quantitative And Qualitative Analysis here

News-ID: 2928275 • Views:

More Releases from Persistence Market Research

Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Persistence Market Research
Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by Sustainability and Supply Chain Efficiency
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Growth - Persistence Market Research
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Healthcare Demand
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained

All 5 Releases


More Releases for Lysosomal

Healthcare Infrastructure Investments Fueling Growth In The Lysosomal Disease Tr …
The Lysosomal Disease Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Lysosomal Disease Treatment Market Size During the Forecast Period? The Lysosomal Disease Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025
Lysosomal Enzyme Market Size, Share, Trends, Demand & Forecast 2034
The Lysosomal Enzyme Market Is Set To Grow At An Estimated CAGR Of 4.4% From 2025 To 2034, Rising From $8.2 Billion In 2024 To $12.5 Billion By 2034. On April 16, 2025, Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of Lysosomal Enzyme market goods. The market study excludes key regions that are accelerating marketization. This section
The Lysosomal Acid Lipase Deficiency (LAL-D) Market: An Overview
Introduction Lysosomal Acid Lipase Deficiency (LAL-D) is a rare genetic disorder characterized by the body's inability to break down certain fats, leading to the accumulation of lipids in various organs. This condition can cause serious health issues, including liver disease, cardiovascular problems, and metabolic disturbances. With growing awareness and advancements in treatment options, the LAL-D market has garnered increasing attention. This post explores the LAL-D market, focusing on its size, share,
Lysosomal Disease Treatment Market Analysis & Forecast by 2026
According to a new report published by Allied Market Research, titled, "Lysosomal Disease Treatment Market: Global Opportunity Analysis and Industry Forecast, 2019-2026" The lysosomal disease treatment market is expected to witness significant growth during the forecast period due to factors such as allocation of orphan drug status to drugs used for treatment of lysosomal disorder. Moreover, rise in awareness related to early diagnosis of lysosomal diseases is another major factor
Lysosomal Acid Lipase Deficiency Treatment Market Report
As per the research conducted by GME, the Global Lysosomal Acid Lipase Deficiency Treatment market will grow with a CAGR value of 10 percent by 2026. Innovative research and advancements for developing reliable and cost-effective therapies, as well as the introduction of novel drugs, is expected to drive substantial expansion in the lysosomal acid lipase deficiency treatment market. Moreover, the increasing incidence of chronic diseases, as well as other uncommon
Lysosomal Alpha Glucosidase Global Market Research Report 2025
Lysosomal Alpha Glucosidase Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/lysosomal-alpha-glucosidase-market/81018 The report firstly introduced the Lysosomal Alpha Glucosidase basics: definitions, classifications, applications